SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-066080
Filing Date
2022-03-04
Accepted
2022-03-04 16:11:27
Documents
14
Period of Report
2022-03-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d203567d8k.htm   iXBRL 8-K 26579
2 EX-99.1 d203567dex991.htm EX-99.1 50767
6 GRAPHIC g203567g0304214325776.jpg GRAPHIC 5710
  Complete submission text file 0001193125-22-066080.txt   220987

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA logc-20220304.xsd EX-101.SCH 2859
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE logc-20220304_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE logc-20220304_pre.xml EX-101.PRE 11709
8 EXTRACTED XBRL INSTANCE DOCUMENT d203567d8k_htm.xml XML 3471
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38707 | Film No.: 22714181
SIC: 2836 Biological Products, (No Diagnostic Substances)